https://cdz173inhibitor.com/sc....ientific-usage-invol
Initial process directed to the modification of epidermis problem and also to neodermis regeneration through the use of an ADM (Integra®, Integra Lifesciences Corp., Plainsboro, NJ, USA) and NPWT. The next treatment 3 months later on directed to the covering of the skin defect with an unmeshed STSG. Both the Integra and skin graft revealed completely using at seven days postop. No major complications occurred. At 6 months grafts gained adequate elasticity to allow the sliding rega
Like
Comment
Share
